Enteral syringes are most commonly used for patients that are admitted in hospital, critical care unit, and NICU. Such patients are unable to ingest medicines and food, therefore, enteral syringes helps in administration of medicines and food. Moreover, Enteral syringes assists in precise measurement of medicines. These syringes are available in purple plunger in order to distinguish them from other types of syringes.

Market Dynamics

Major factor driving growth of the enteral syringe market is increasing prevalence of chronic diseases such as cancer, which often results in hospital admissions in late stage of the disease. These patients are unable to ingest any kind of food and medicines, therefore, enteral syringes are preferred in such situations. According to a report by International Agency for Research on Cancer, titled GLOBOSCAN, September 2018, around 18.1 million new cancer cases and 9.6 million cancer deaths were recorded in 2018, worldwide. Moreover, same source mentions that, one out of every five men and one out of every six women worldwide suffer from cancer during their lifetime and one out of every eight men and one out of every 11 women die from the disease. The total number of people surviving within 5 years of a cancer diagnosis, called the 5-year prevalence, is around 43.8 million, worldwide. Another major factor for growth of this market is changed syringe design adopted internationally which ensures extra safety and allows wider use of enteral syringe devices worldwide. In the year 2018, several manufacturers launched ENFit compliant enteral syringe in the market which would help in expansion of the market

Key features of the study

• This report provides in-depth analysis of the global enteral syringe market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new products launched, market trends,  regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global enteral syringe market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include, B. Braun Melsungen AG, GBUK Enteral Ltd., Thermo Fischer, Inc., Koninklijke Philips N.V., Miktell Ltd., Baxter International, Inc., Cardinal Health, Inc., Terumo Corporation, Kentec Medical, Inc., and Vygon S.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, product up-gradation, market expansion, and marketing tactics
• The global enteral syringe market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the enteral syringe market

Market Segmentation

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Single Use Enteral Syringes
  • Home Use Enteral Syringes
  • Catheter Tip Syringes
  • Others
• By Application (Revenue, USD Bn, 2021-2033)
  • Cancer
  • Malnutrition
  • Neurological Disease
  • GI Related Disease
  • Others
• By Patient Group (Revenue, USD Bn, 2021-2033)
  • Neonates and Pediatrics
  • Adults
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals and Ambulatory Care Centers
  • Home-based User
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Braun Melsungen AG
  • GBUK Enteral Ltd.
  • Thermo Fischer, Inc.
  • Koninklijke Philips N.V.
  • Miktell Ltd.
  • Baxter International, Inc.
  • Cardinal Health, Inc.
  • Terumo Corporation
  • Kentec Medical, Inc.
  • Vygon S.A.